世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000037722

子宮頸がん治療薬の世界市場レポート(2024年)

The Business Research Company

Cervical Cancer Drugs Global Market Report 2024

発刊日 2024/02/23

言語英語

体裁PDF/175ページ

ライセンス/価格175ページ

0000037722

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、子宮頸がん治療薬の世界市場に関して、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

本レポートは、力強い成長を遂げている子宮頸がん治療薬市場に焦点を当て、今後10年およびそれ以降の市場を形成するトレンドについてのガイドを提供します。

調査範囲

  • 調査市場
    ➣ がんの種類別
      ◇ 扁平上皮がん
      ◇ 腺がん
    ➣ 薬剤の種類別
      ◇ アバスチン
      ◇ ベバシズマブ
      ◇ ブレオマイシン
      ◇ ブレノキサン
      ◇ 他の種類の薬剤
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ その他の流通チャネル
  • 調査企業
    ➣ Pfizer Inc.
    ➣ Johnson & Johnson Services Inc.
    ➣ F. Hoffmann-La Roche Ltd.
    ➣ Merck & Co. Inc.
    ➣ Bayer AG
  • 調査国
    オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、イギリス、アメリカ、カナダ、イタリア、スペイン
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
  • 提供形態
    ➣ PDF、Word、Excelデータダッシュボード

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Cervical Cancer Drugs Market Characteristics

3. Cervical Cancer Drugs Market Trends And Strategies

4. Cervical Cancer Drugs Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Cervical Cancer Drugs Market Size and Growth
5.1. Global Cervical Cancer Drugs Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Cervical Cancer Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Cervical Cancer Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cervical Cancer Drugs Market Segmentation
6.1. Global Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Squamous Cell Cancer
Adenocarcinoma
6.2. Global Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Avastin
Bevacizumab
Blemocin
Blenoxane
Other Drug Types
6.3. Global Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals Pharmacies
Retail Pharmacies
Other Distribution Channels

7. Cervical Cancer Drugs Market Regional And Country Analysis
7.1. Global Cervical Cancer Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Cervical Cancer Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cervical Cancer Drugs Market
8.1. Asia-Pacific Cervical Cancer Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cervical Cancer Drugs Market
9.1. China Cervical Cancer Drugs Market Overview
9.2. China Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cervical Cancer Drugs Market
10.1. India Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cervical Cancer Drugs Market
11.1. Japan Cervical Cancer Drugs Market Overview
11.2. Japan Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cervical Cancer Drugs Market
12.1. Australia Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cervical Cancer Drugs Market
13.1. Indonesia Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cervical Cancer Drugs Market
14.1. South Korea Cervical Cancer Drugs Market Overview
14.2. South Korea Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cervical Cancer Drugs Market
15.1. Western Europe Cervical Cancer Drugs Market Overview
15.2. Western Europe Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cervical Cancer Drugs Market
16.1. UK Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cervical Cancer Drugs Market
17.1. Germany Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cervical Cancer Drugs Market
18.1. France Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cervical Cancer Drugs Market
19.1. Italy Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cervical Cancer Drugs Market
20.1. Spain Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cervical Cancer Drugs Market
21.1. Eastern Europe Cervical Cancer Drugs Market Overview
21.2. Eastern Europe Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cervical Cancer Drugs Market
22.1. Russia Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cervical Cancer Drugs Market
23.1. North America Cervical Cancer Drugs Market Overview
23.2. North America Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cervical Cancer Drugs Market
24.1. USA Cervical Cancer Drugs Market Overview
24.2. USA Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cervical Cancer Drugs Market
25.1. Canada Cervical Cancer Drugs Market Overview
25.2. Canada Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cervical Cancer Drugs Market
26.1. South America Cervical Cancer Drugs Market Overview
26.2. South America Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cervical Cancer Drugs Market
27.1. Brazil Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cervical Cancer Drugs Market
28.1. Middle East Cervical Cancer Drugs Market Overview
28.2. Middle East Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cervical Cancer Drugs Market
29.1. Africa Cervical Cancer Drugs Market Overview
29.2. Africa Cervical Cancer Drugs Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Cervical Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Cervical Cancer Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cervical Cancer Drugs Market Competitive Landscape And Company Profiles
30.1. Cervical Cancer Drugs Market Competitive Landscape
30.2. Cervical Cancer Drugs Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson & Johnson Services Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. F. Hoffmann-La Roche Ltd.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Merck & Co. Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Bayer AG
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance

31. Cervical Cancer Drugs Market Other Major And Innovative Companies
31.1. Novartis AG
31.2. Sanofi S.A.
31.3. Bristol Myers Squibb Company
31.4. AstraZeneca plc
31.5. GlaxoSmithKline plc
31.6. Eli Lilly and Company
31.7. Amgen Inc.
31.8. Siemens Healthineers AG
31.9. Allergan plc
31.10. Teva Pharmaceutical Industries Ltd.
31.11. Mylan NV
31.12. Hetero Drugs Limited
31.13. Sun Pharmaceutical Industries Limited
31.14. Genentech Inc.
31.15. QIAGEN NV

32. Global Cervical Cancer Drugs Market Competitive Benchmarking

33. Global Cervical Cancer Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cervical Cancer Drugs Market

35. Cervical Cancer Drugs Market Future Outlook and Potential Analysis
35.1 Cervical Cancer Drugs Market In 2028 - Countries Offering Most New Opportunities
35.2 Cervical Cancer Drugs Market In 2028 - Segments Offering Most New Opportunities
35.3 Cervical Cancer Drugs Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies

36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

この商品のレポートナンバー

0000037722

TOP